SG11201704791WA - Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof - Google Patents

Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof

Info

Publication number
SG11201704791WA
SG11201704791WA SG11201704791WA SG11201704791WA SG11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA
Authority
SG
Singapore
Prior art keywords
azepine
dipropyl
carboxamide
pyrrolidine
benzo
Prior art date
Application number
SG11201704791WA
Inventor
Hon-Wah Man
Timothy D Fitzpatrick
Anthony Frank
Ying Li
Xiaoling Lu
Marie G Beauchamps
Antonio C Ferretti
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of SG11201704791WA publication Critical patent/SG11201704791WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201704791WA 2014-12-16 2015-12-15 Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof SG11201704791WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462092764P 2014-12-16 2014-12-16
PCT/US2015/065755 WO2016100302A2 (en) 2014-12-16 2015-12-15 Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof

Publications (1)

Publication Number Publication Date
SG11201704791WA true SG11201704791WA (en) 2017-07-28

Family

ID=56127832

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704791WA SG11201704791WA (en) 2014-12-16 2015-12-15 Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof

Country Status (12)

Country Link
US (2) US20190100512A1 (en)
EP (1) EP3233088A4 (en)
JP (2) JP6707088B2 (en)
KR (1) KR20170118700A (en)
AU (1) AU2015362720B2 (en)
BR (1) BR112017012646A2 (en)
CA (1) CA2970358A1 (en)
EA (1) EA201791346A1 (en)
IL (1) IL252744A0 (en)
MX (1) MX2017007955A (en)
SG (1) SG11201704791WA (en)
WO (1) WO2016100302A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201704791WA (en) 2014-12-16 2017-07-28 Celgene Corp Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof
EP3595668B1 (en) 2017-03-15 2021-07-21 Silverback Therapeutics, Inc. Benzazepine compounds, conjugates, and uses thereof
CN109320456A (en) * 2018-11-16 2019-02-12 天津商业大学 Antitumoral compounds of novel crystal forms and preparation method thereof and composition containing it
EP4106819A1 (en) 2020-02-21 2022-12-28 Silverback Therapeutics, Inc. Nectin-4 antibody conjugates and uses thereof
WO2022006327A1 (en) 2020-07-01 2022-01-06 Silverback Therapeutics, Inc. Anti-asgr1 antibody conjugates and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (en) 1989-03-22 1991-07-25 Bioresearch Spa USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (en) 1994-07-07 1997-05-07 Recordati Chem Pharm CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
CZ20022332A3 (en) * 2000-01-07 2003-01-15 Transform Pharmaceuticals, Inc. Sample assembly
TW201402124A (en) 2005-08-19 2014-01-16 Array Biopharma Inc 8-substituted benzoazepines as toll-like receptor modulators
DK2313111T3 (en) * 2008-08-01 2013-12-02 Ventirx Pharmaceuticals Inc Toll-like receptor agonist formulations and their use
EP2358683B1 (en) 2008-11-06 2015-04-01 VentiRx Pharmaceuticals, Inc. Methods of synthesis of benzazepine derivatives
WO2012045089A2 (en) * 2010-10-01 2012-04-05 Ventirx Pharmaceuticals, Inc. Methods for the treatment of allergic diseases
SG11201704791WA (en) 2014-12-16 2017-07-28 Celgene Corp Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof

Also Published As

Publication number Publication date
US20200002316A1 (en) 2020-01-02
BR112017012646A2 (en) 2018-01-02
EA201791346A1 (en) 2018-01-31
US10604510B2 (en) 2020-03-31
WO2016100302A3 (en) 2016-09-15
JP6707088B2 (en) 2020-06-10
EP3233088A4 (en) 2018-09-19
CA2970358A1 (en) 2016-06-23
AU2015362720A1 (en) 2017-07-06
JP2020079261A (en) 2020-05-28
WO2016100302A2 (en) 2016-06-23
MX2017007955A (en) 2018-02-19
US20190100512A1 (en) 2019-04-04
JP2017537962A (en) 2017-12-21
EP3233088A2 (en) 2017-10-25
KR20170118700A (en) 2017-10-25
IL252744A0 (en) 2017-08-31
AU2015362720B2 (en) 2019-11-21

Similar Documents

Publication Publication Date Title
IL272089B1 (en) Compounds, compositions and methods
IL276695B (en) Antibodies, pharmaceutical compositions and uses thereof
ZA201605210B (en) Thermoassociative and exchangeable copolymers, and compositions comprising same
HUE062446T2 (en) Compounds, compositions and methods
EP3179870C0 (en) Antimicrobial compounds and compositions, and uses thereof
IL249646A0 (en) Platinum compounds, compositions, and uses thereof
GB201423376D0 (en) Antimicrobial compounds, compositions and methods
IL247319A0 (en) Triazine compounds, compositions comprising same and uses thereof
IL252744A0 (en) Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof
PL3223796T3 (en) Pharmaceutical compositions, preparation and uses thereof
PT3552017T (en) Compounds, compositions and methods
IL252397A0 (en) Pharmaceutical composition, preparation and uses thereof
IL252897A0 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
IL248783A0 (en) Quencher compounds, compositions comprisingsame and uses thereof
IL290114A (en) Pharmaceutical composition, preparation and uses thereof
EP3313393A4 (en) Platinum compounds, compositions, and uses thereof
IL248256B (en) Cyclohexenyl compounds, compositions comprising them and uses thereof
PL3229843T3 (en) Pharmaceutical composition, preparation and uses thereof
EP3148996A4 (en) C2-carbocyclic iminothiazine dioxides as bace inhibitors, compositions, and their use
IL270505B1 (en) Compounds, compositions and methods
EP3237399A4 (en) Compounds, compositions and methods
GB201513614D0 (en) Compositions, compounds and methods and uses relating thereto
EP3194396A4 (en) Diazine-fused amidine compounds as bace inhibitors, compositions, and their use
EP3191447A4 (en) S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
EP3313392A4 (en) Platinum compounds, compositions, and uses thereof